Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolò Bolli, Hervé Avet‐Loiseau, David C. Wedge, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 823

Showing 1-25 of 823 citing articles:

Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan, Charles Swanton
Cell (2017) Vol. 168, Iss. 4, pp. 613-628
Open Access | Times Cited: 2354
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem, Peter Van Loo, Bárbara Kremeyer, et al.
Nature (2015) Vol. 520, Iss. 7547, pp. 353-357
Open Access | Times Cited: 1333
Universal Patterns of Selection in Cancer and Somatic Tissues
Iñigo Martincorena, Keiran Raine, Moritz Gerstung, et al.
Cell (2017) Vol. 171, Iss. 5, pp. 1029-1041.e21
Open Access | Times Cited: 1312
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
Elza C. de Bruin, Nicholas McGranahan, Richard Mitter, et al.
Science (2014) Vol. 346, Iss. 6206, pp. 251-256
Open Access | Times Cited: 1051
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan, Charles Swanton
Cancer Cell (2015) Vol. 27, Iss. 1, pp. 15-26
Open Access | Times Cited: 1007
Multiple myeloma
Shaji Kumar, S. Vincent Rajkumar, Robert A. Kyle, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 958
Mutational signatures associated with tobacco smoking in human cancer
Ludmil B. Alexandrov, Young Seok Ju, Kerstin Haase, et al.
Science (2016) Vol. 354, Iss. 6312, pp. 618-622
Open Access | Times Cited: 934
Clock-like mutational processes in human somatic cells
Ludmil B. Alexandrov, Philip H. Jones, David C. Wedge, et al.
Nature Genetics (2015) Vol. 47, Iss. 12, pp. 1402-1407
Open Access | Times Cited: 918
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Jianjun Zhang, Junya Fujimoto, Jianhua Zhang, et al.
Science (2014) Vol. 346, Iss. 6206, pp. 256-259
Open Access | Times Cited: 908
Subclonal diversification of primary breast cancer revealed by multiregion sequencing
Lucy Yates, Moritz Gerstung, Stian Knappskog, et al.
Nature Medicine (2015) Vol. 21, Iss. 7, pp. 751-759
Open Access | Times Cited: 766
T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
Jennifer N. Brudno, Irina Marić, Steven D. Hartman, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 22, pp. 2267-2280
Open Access | Times Cited: 699
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan, Francesco Favero, Elza C. de Bruin, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 283
Open Access | Times Cited: 649
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell, et al.
Journal of Clinical Oncology (2015) Vol. 33, Iss. 33, pp. 3911-3920
Open Access | Times Cited: 519
Genomic complexity of multiple myeloma and its clinical implications
Salomon Manier, Karma Z. Salem, Jihye Park, et al.
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 2, pp. 100-113
Closed Access | Times Cited: 476
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J. Mitchell, Samra Turajlic, Andrew Rowan, et al.
Cell (2018) Vol. 173, Iss. 3, pp. 611-623.e17
Open Access | Times Cited: 475
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
Charles Swanton, Nicholas McGranahan, Gabriel J. Starrett, et al.
Cancer Discovery (2015) Vol. 5, Iss. 7, pp. 704-712
Open Access | Times Cited: 457
SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
Christopher A. Miller, Brian S. White, Nathan D. Dees, et al.
PLoS Computational Biology (2014) Vol. 10, Iss. 8, pp. e1003665-e1003665
Open Access | Times Cited: 451
Detecting ultralow-frequency mutations by Duplex Sequencing
Scott R. Kennedy, Michael W. Schmitt, Edward Fox, et al.
Nature Protocols (2014) Vol. 9, Iss. 11, pp. 2586-2606
Open Access | Times Cited: 437
Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, et al.
Blood (2018) Vol. 132, Iss. 6, pp. 587-597
Open Access | Times Cited: 413
Translational Implications of Tumor Heterogeneity
Mariam Jamal‐Hanjani, Sergio A. Quezada, James Larkin, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 6, pp. 1258-1266
Open Access | Times Cited: 398
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
Masaru Katoh
International Journal of Oncology (2017) Vol. 51, Iss. 5, pp. 1357-1369
Open Access | Times Cited: 395
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes
Stefan C. Dentro, Ignaty Leshchiner, Kerstin Haase, et al.
Cell (2021) Vol. 184, Iss. 8, pp. 2239-2254.e39
Open Access | Times Cited: 391
Hypermutation in human cancer genomes: footprints and mechanisms
Steven A. Roberts, Dmitry A. Gordenin
Nature reviews. Cancer (2014) Vol. 14, Iss. 12, pp. 786-800
Open Access | Times Cited: 388
Tumour heterogeneity and the evolution of polyclonal drug resistance
Rebecca A. Burrell, Charles Swanton
Molecular Oncology (2014) Vol. 8, Iss. 6, pp. 1095-1111
Open Access | Times Cited: 385
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis
Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell, et al.
Leukemia (2018) Vol. 33, Iss. 1, pp. 159-170
Open Access | Times Cited: 379
Page 1 - Next Page

Scroll to top